Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Eloralintide And Tirzepatide

A Study of Eloralintide (LY3841136) and Eloralintide With Tirzepatide in Participants With Overweight or Obesity

Eli Lilly · Phase 1 · Completed · Enrollment 188

NCT06916065

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
Eloralintide and Tirzepatide-Cohorts A-Dn/rn/rn/rn/r
Eloralintide-Cohorts E and Fn/rn/rn/rn/r

Not shown

  • Eloralintide and Tirzepatide-Cohorts A-D: endpoint not reported
  • Eloralintide-Cohorts E and F: endpoint not reported